Bachem Holding AG (0QND.L)
0QND.L Stock Price Chart
Explore Bachem Holding AG interactive price chart. Choose custom timeframes to analyze 0QND.L price movements and trends.
0QND.L Company Profile
Discover essential business fundamentals and corporate details for Bachem Holding AG (0QND.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
3 Dec 2015
Employees
2.21K
Website
https://www.bachem.comCEO
Thomas Meier
Description
Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. The company was founded in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.
0QND.L Financial Timeline
Browse a chronological timeline of Bachem Holding AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 25 Feb 2026
Earnings released on 24 Jul 2025
EPS came in at CHF 0.67 surpassing the estimated CHF 0.51 by +31.37%, while revenue for the quarter reached CHF 312.99M , beating expectations by +17.19%.
Dividend declared on 5 May 2025
A dividend of CHF 0.85 per share was announced, adjusted to CHF 0.85. The dividend was paid on 7 May 2025.
Earnings released on 27 Feb 2025
EPS came in at CHF 1.12 falling short of the estimated CHF 1.17 by -4.27%, while revenue for the quarter reached CHF 364.95M , missing expectations by -2.11%.
Earnings released on 25 Jul 2024
EPS came in at CHF 0.48 surpassing the estimated CHF 0.39 by +23.08%, while revenue for the quarter reached CHF 240.31M , missing expectations by -3.15%.
Dividend declared on 26 Apr 2024
A dividend of CHF 0.80 per share was announced, adjusted to CHF 0.80. The dividend was paid on 30 Apr 2024.
Earnings released on 7 Mar 2024
EPS came in at CHF 1.03 , while revenue for the quarter reached CHF 337.46M , beating expectations by +5.36%.
Earnings released on 30 Jun 2023
EPS came in at CHF 0.46 falling short of the estimated CHF 0.48 by -4.17%, while revenue for the quarter reached CHF 239.86M , beating expectations by +4.30%.
Dividend declared on 21 Apr 2023
A dividend of CHF 0.75 per share was announced, adjusted to CHF 0.75. The dividend was paid on 25 Apr 2023.
Earnings released on 31 Dec 2022
EPS came in at CHF 0.87 falling short of the estimated CHF 0.98 by -11.33%, while revenue for the quarter reached CHF 296.86M , missing expectations by -2.30%.
Earnings released on 30 Jun 2022
EPS came in at CHF 0.50 falling short of the estimated CHF 0.74 by -32.53%, while revenue for the quarter reached CHF 234.88M , missing expectations by -7.36%.
Stock split effective on 18 May 2022
Shares were split 5 : 1 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 5 May 2022
Shares were split 5 : 1 , changing the number of shares outstanding and the price per share accordingly.
Dividend declared on 29 Apr 2022
A dividend of CHF 17.50 per share was announced, adjusted to CHF 3.50. The dividend was paid on 3 May 2022.
Earnings released on 31 Dec 2021
EPS came in at CHF 0.86 falling short of the estimated CHF 0.88 by -2.05%, while revenue for the quarter reached CHF 264.09M , missing expectations by -4.45%.
Earnings released on 30 Jun 2021
EPS came in at CHF 0.76 surpassing the estimated CHF 0.72 by +5.71%, while revenue for the quarter reached CHF 239.14M , beating expectations by +2.28%.
Dividend declared on 30 Apr 2021
A dividend of CHF 16.25 per share was announced, adjusted to CHF 3.25. The dividend was paid on 4 May 2021.
Earnings released on 31 Dec 2020
EPS came in at CHF 0.65 surpassing the estimated CHF 0.58 by +10.62%, while revenue for the quarter reached CHF 224.86M , beating expectations by +4.24%.
0QND.L Stock Performance
Access detailed 0QND.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.